Drug Profile
Golotimod
Alternative Names: Gamma-D-glutamyl-L-tryptophan; SCV-07Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Verta
- Developer SciClone Pharmaceuticals; Verta
- Class Antineoplastics; Antituberculars; Dipeptides; Small molecules
- Mechanism of Action STAT3 transcription factor inhibitors; Th1 cell stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Hepatitis C; Tuberculosis
- No development reported Asthma; Cancer; Herpesvirus infections; Human papillomavirus infections
- Discontinued Stomatitis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Asthma in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in USA (SC, Injection)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Herpesvirus-infections in USA